Drug class
Interleukin-5 Antagonist
Mechanism of action
Interleukin-5 Antagonists [MoA]
General use cases
- Asthma
- acute bronchospasm or status asthmaticus [see Warnings and Precautions ( 5
- acute bronchospasm [see Warnings and Precautions ( 5
- adult patients with eosinophilic granulomatosis with polyangiitis (EGPA)
- adult and pediatric patients aged 12 years and older with hypereosinophilic syndrome (HES) for greater than or equal to 6 months without an identifiable non-hematologic secondary cause
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
